Skip to content

Study On The Effect Of Medicated Enema And Ayurveda Oral Medicine In Management Of Medoroga (Dyslipidemia)

A Comparative Clinical Study To Evaluate The Efficacy Of Triphala Kwatha With Madhu Administered Orally And As Kala Basti(Rectal Administration) In The Management Of Medoroga(Dyslipidemia)

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/06/019560
Enrollment
30
Registered
2019-06-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E784- Other hyperlipidemia

Interventions

Intervention1: Triphala kwatha with other conventional drugs(Madhu, saindhav,Triphala taila, shatpushpa,Triphala kwatha ) as kala basti for 15 days: Anuvasan basti- Triphala Taila-60 ML ON 1,2,4,6,8,1

Sponsors

All India Institute Of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Serum Cholesterol (201 mg/dl or more) Serum TGLs (161 mg/dl or more) Serum HDL (below 40 mlg/dl) Serum LDL (131 mg/dl or more) Serum VLDL (41 mg/dl or more) will be included in the study.

Exclusion criteria

Exclusion criteria: Systemic Disorders Like Cardiac Disease,Renal Disease, And Neurological Diseases And Who Are Not Fit For Basti Karma Will Be Excluded.

Design outcomes

Primary

MeasureTime frame
To compare the efficacy of Triphala kwatha administered in the schedule of Kala Basti rectal administration and oral administration of Triphala kwatha with Madhu in the management of Medoroga w.r.s to dyslipidemia. Timepoint: 3 month

Secondary

MeasureTime frame
Overall improvement in Quality of life in Dyslipidemia. Reduction in sign and symptoms of Medoroga w.s.r. to Dyslipidemia Timepoint: 90 days

Countries

India

Contacts

Public ContactDr Santoshkumar Bhatted

All India Institute Of Ayurveda

santoshbhatted@rediffmail.com9414048459

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026